Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY23 results · Jul–Sep 2022
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,044.89 crore (down 1.3% from Q2 FY22) and net profit of ₹154.41 crore (down 29.3% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a standalone basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,044.89 | 1,058.30 | −1.3% | 776.38 | +34.6% |
| Other income | 6.73 | 5.80 | +16.0% | 5.63 | +19.5% |
| Total income | 1,051.62 | 1,064.10 | −1.2% | 782.01 | +34.5% |
| Profit before tax | 205.80 | 293.84 | −30.0% | 57.70 | +256.7% |
| Net profit for the period | 154.41 | 218.29 | −29.3% | 42.55 | +262.9% |
| EPS, basic (₹) | 47.57 | 67.25 | −29.3% | 13.11 | +262.9% |
| Net margin (%) | 14.8 | 20.6 | 5.5 |
Standalone
- Filed with BSE
- 03 Nov 2022, 07:24 IST
- Board meeting
- 02 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE